“Efficacy of ChemoID® Guided Drug Selection for Palliative Chemotherapy in Advanced Recurrent High-Grade Ovarian Adenocarcinoma: Case Study”. Translational Medicine Reports, vol. 2, no. 1, Oct. 2017, https://doi.org/10.4081/tmr.6701.